Our previous report revealed that miR-483-3p could enhance the growth, migration, and drug resistance of ESCC via targeting EI24, indicating that EI24 is implicated in the tumorigenesis and/or development of ESCC (17). Here, EI24 is linked to esophageal squamous cell carcinoma.